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E-mail address: tatibana@agr.kyushu-u.ac.jp (H. TaImmunoglobulin E (IgE) production is induced by interleukin (IL)-4 signaling mediated by type I IL-4
receptor (IL-4R) in B cells. We found that ﬂavones inhibited IL-4-induced e germline transcription
which is essential for IgE class switching, and the phosphorylation of signal transducer and activator
of transcription 6, janus kinase 3, and IL-4Ra, whereas IL-4 signaling mediated through type II IL-4R
was unaffected by ﬂavones. Furthermore, ﬂavones reduced the expression of common gamma
chain, a characteristic constituent subunit of type I IL-4R, suggesting that ﬂavones suppress type I
IL-4R signaling.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Flavonoids are the diverse family of chemicals commonly foundImmunoglobulin (Ig) E was previously identiﬁed as a key mole-
cule mediating type I hypersensitivity reactions [1]. Interleukin
(IL)-4 controls the speciﬁcity of immunoglobulin class switching
and induces B cells to produce IgE [2]. For IgE class switching,
expression of e germline transcript (eGT), which binds to the
appropriate heavy chain switch region sequence, is induced by
IL-4 [3]. IL-4R is divided into two types by the difference of sub-
units. Type I IL-4R uses IL-4Ra and common gamma chain (cc) as
a component of their receptors and type II IL-4R consists of IL-
4Ra and IL-13Ra1 [4]. Because cc expression is restricted to hema-
topoietic cells, type I IL-4R is mainly expressed in hematopoietic
cells, whereas type II IL-4R is ubiquitously expressed [5]. cc has
no ability to bind IL-4 directly but is important for signaling of
the type I receptor [4].chemical Societies. Published by E
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chibana).in many fruits and vegetables. Flavonoids are plant polyphenolic
compounds which have a diphenylpropane skeleton (C6C3C6)
structure which includes monomeric ﬂavanols, ﬂavanones, ﬂav-
ones, and ﬂavonols. Some ﬂavonoids have been found to possess
various clinically relevant properties such as anti-tumor and
anti-inﬂammatory activities [6,7]. Our previous reports demon-
strated that dietary apigenin, one of ﬂavones, could suppress ser-
um IgE production in C57BL/6N mice [8] and antigen-speciﬁc IgE
production in BALB/c mice immunized by ovalbumine [9] and in
NC/Nga mice sensitized with hapten [10]. In this study, we inves-
tigated the molecular basis for the ﬂavones functions that reduce
IgE production. Here we show that ﬂavones can suppress type I
IL-4R signaling by reducing the cell surface expression of cc.
2. Materials and methods
2.1. Reagents
Chrysin and apigenin were purchased from Sigma–Aldrich (St.
Louis, MO, USA) and dissolved in dimethylsulfoxide (DMSO).
Anti-STAT6, anti-JAK3, anti-IL-4Ra, anti-PPARc, and anti-phospho-
tyrosine (PY20) antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Human recombinant IL-4,lsevier B.V. All rights reserved.
Fig. 1. Effect of ﬂavones on IL-4-induced eGT expression. DND39 cells were treated
with indicated concentrations of ﬂavones and IL-4 (25 U/ml) for 48 h. Total mRNA
was isolated from cells and the expression of eGT was analyzed by RT-PCR.
Fig. 2. Effect of ﬂavones on IL-4-induced STAT6 phosphorylation. DND39 cells were
treated with IL-4 (100 U/ml) for 30 min after treatment with ﬂavones for 24 h. Total
cell lysate was immunoprecipitated using anti-STAT6 antibodies and then immu-
noblotted using anti-phosphotyrosine and anti-STAT6 antibodies.
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body were purchased from R&D Systems (Minneapolis, MN).
2.2. Cells and cell culture
The human mature B cell line DND39 was cultured at 37 C un-
der humidiﬁed 5% CO2/95% air in RPMI 1640 medium (Nissui, To-
kyo, Japan) supplemented with 5% fetal bovine serum (FBS)
(Biological Industries, Beit Haemek, Israel), 100 U/ml penicillin G,
100 mg/ml streptomycin, and 10 mM HEPES buffer. As vehicle,
0.1% of DMSO was added to control cells.
2.3. Analysis of eGT expression
DND39 cells were treated with IL-4 (25 U/ml) with or without
ﬂavones for 48 h. The expression level of eGT was measured with
the reverse transcriptase-polymerase chain reaction (RT-PCR)
method as previously described [11].
2.4. Immunoprecipitation and immunoblotting
After treatment with or without ﬂavones for 24 h, DND39 cells
were stimulated with IL-4 (100 U/ml) for 30 min. Then, assessmentFig. 3. Involvement of PPARc on the inhibitory effect of ﬂavones on IL-4-induced STAT6 p
transfected in DND39, and the expression of PPARc was examined by immunoblotting. (
treatment with ﬂavones (10 lM) or pioglitazone (5 lM) for 24 h. Total cell lysate was im
phosphotyrosine and anti-STAT6 antibodies.of the phosphorylation of STAT6, JAK3, and IL-4Ra were performed
by immunoprecipitation and immunoblotting as previously de-
scribed [11].
2.5. Silencing of PPARc
Peroxisome proliferator-activated receptor (PPAR) c-silencing
DND39 cells were constructed by the method of RNA interference
using psiRNA-hH1hygro G2 Kit (Invivogen, San Diego, CA). The tar-
get sequence for short hairpin RNAs for PPARc is as follows: 50-GTT
TGA GTT TGC TGT GAA G-30. PPARc-shRNA expression vector was
transfected into the cells by electroporation and the cells were se-
lected by Hygromycine B (Roche). The PPARc expression level was
assessed by immunoblotting analysis.
2.6. Fluorescent immunostaining of IL-4
Cell surface binding of IL-4 was assessed by ﬂuorescent immu-
nostaining. After the treatment of ﬂavones, DND39 cells were incu-
bated with biotinylated human IL-4 and were incubated with
quantum dot 655 streptavidin conjugates (Invitrogen, Carlsbad,
CA). Detection of IL-4 on the cell surface was performed using ﬂuo-
rescent microscope (BZ-HIA/HIT2/HIM2, Keyence, Osaka, Japan).
2.7. Analysis of cc expression
The cell surface expression of cc was assessed by ﬂow cytome-
try using anti-human CD132/cc monoclonal antibody following
the appended protocol. Mouse IgG2A isotype control-CFS (R&D Sys-
tems) was used as the isotype-matched negative control. The pro-
tein expression level of cc was assessed by immunoblotting
analysis.
3. Results
3.1. Flavones inhibited IL-4-induced eGT expression
Expression of eGT is essential for IL-4-induced IgE class
switching [3]. We examined the effect of chrysin and apigenin on
IL-4-induced eGT expression in DND39 cells. Both ﬂavones dose-
dependently inhibited the expression of eGT (Fig. 1).
3.2. Flavones inhibited IL-4-induced STAT6 phosphorylation
IL-4 activates the signal transducer and activator of transcrip-
tion (STAT) 6 transcription factor which interacts with the
promoter region for eGT [12]. STAT6 plays an essential role in IL-
4-induced eGT expression [13], and IgE class switching cannot be
seen in mice with a disrupted STAT6 gene [14]. We examined thehosphorylation. (A) Scramble-shRNA or PPARc-shRNA expression vector were stably
B) PPARc-silencing DND39 cells were treated with IL-4 (100 U/ml) for 30 min after
munoprecipitated using anti-STAT6 antibodies and then immunoblotted using anti-
Fig. 4. Effects of ﬂavones on IL-4-induced phosphorylation of JAK3 and IL-4Ra.
DND39 cells were treated with IL-4 (100 U/ml) for 30 min after treatment with
ﬂavones for 24 h. Total cell lysate was immunoprecipitated using (A) anti-JAK3 or
(B) anti-IL-4Ra antibodies and then immunoblotted.
Fig. 6. Effect of ﬂavones on IL-4-induced STAT6 phosphorylation in type II IL-4R.
HeLa cells were treated with IL-4 (100 U/ml) for 30 min after treatment with 25 lM
of ﬂavones for 24 h. Total cell lysate was immunoprecipitated using anti-STAT6
antibodies and then immunoblotted using anti-phospho tyrosine and anti-STAT6
antibodies.
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shown in Fig. 2, chrysin and apigenin dose-dependently inhibited
STAT6 phosphorylation induced by IL-4.
3.3. Flavones inhibited IL-4-induced STAT6 phosphorylation
independently of PPARc
PPARc is a member of the nuclear hormone receptors superfam-
ily. Recently, it has been reported that some ﬂavonoids including
chrysin and apigenin exhibit PPARc agonist activities [15]. In addi-
tion, we reported that PPARc ligands inhibit IL-4-induced eGT
expression in DND39 cells [16]. Therefore, we investigated
whether the inhibitory activity of ﬂavones on IL-4-induced STAT6
phosphorylation is mediated through PPARc. Western blot analysis
indicated that stable RNAi for PPARc speciﬁcally silenced PPARc
protein expression (Fig. 3A). Pioglitazone, one of PPARc ligands,
suppressed IL-4-induced STAT6 phosphorylation, and this inhibi-
tory activity was completely abrogated in the PPARc-silencing
cells. On the other hand, the inhibitory activity of the ﬂavones on
IL-4-induced STAT6 phosphorylation was not affected in the
PPARc-ablating cells (Fig. 3B), suggesting that ﬂavones suppress
IL-4 signaling independently of PPARc.
3.4. Flavones inhibited IL-4-induced JAK3 and IL-4Ra phosphorylation
Activation of Janus kinases (JAKs) results in phosphorylation of
the cytoplasmic tyrosines in IL-4Ra, leading to the recruitment of
STAT6 to the receptor, followed by STAT6 phosphorylation and
activation [4]. We examined the effect of ﬂavones on the IL-4-in-
duced phosphorylation of JAK3 and IL-4Ra in DND39 cells. As
shown in Fig. 4, the phosphorylation of JAK3 and IL-4Ra induced
by IL-4 were inhibited by ﬂavones.Fig. 5. Effect of ﬂavones on IL-4 binding. DND39 cells were treated with biotinylated hum
mixed with Qdot-streptavidin and IL-4 on cell surface was detected by using ﬂuorescen3.5. IL-4 binding was unaffected by ﬂavones
Next, we examined whether ﬂavones inhibit IL-4 binding to IL-
4R using ﬂuorescent immunostaining. Cell surface binding of IL-4
was unaffected by ﬂavones (Fig. 5), suggesting that the inhibitory
activity of ﬂavones on IL-4 signaling is not due to the inhibition
of IL-4 binding to IL-4R.
3.6. Flavones had no effect on IL-4-induced STAT6 phosphorylation in
HeLa cells
We investigated whether ﬂavones suppress type II IL-4 signal-
ing in type II IL-4R-expressing HeLa cells. Interestingly, IL-4-in-
duced STAT6 phosphorylation in HeLa cells was unaffected by
ﬂavones (Fig. 6), suggesting that cc may be a critical target for
the inhibitory activity of ﬂavones on IL-4 signaling.
3.7. Flavones down-regulated common gamma chain expression
We examined the effect of ﬂavones on the cell surface expres-
sion of cc in DND39 cells. The two ﬂavones dose-dependently re-
duced the cell surface expression level of cc (Fig. 7A). We also
found that ﬂavones reduced the protein level of cc (Fig. 7B). These
results suggest that the inhibitory activity of ﬂavones on IL-4-in-
duced eGT expression may be in part due to the downregulation
of cc protein.
4. Discussion
IgE plays a key role in the pathogenesis of allergic disease [1].
IL-4 is critical for the synthesis of IgE in B cells [2]. Inhibition of
IL-4 signaling may therefore be effective in inhibiting allergy dis-
ease. eGT expression induced by IL-4 is essential for IgE class
switching [3]. Here we identiﬁed ﬂavones as inhibitory molecules
that inhibit IL-4-induced eGT expression.an IL-4 for 60 min after treatment with 25 lM of ﬂavones for 24 h. Then cells were
ce microscope.
Fig. 7. Effect of ﬂavones on the expression of cc. DND39 cells were treated with ﬂavones for 24 h. (A) The expression of cc on the cell surface was assessed using ﬂow
cytometry analysis. Results were assessed as the Normalized Mean Fluorescence Index (NMFI). (B) The intracellular expression of cc was detected by immunoblot analysis.
The relative level of cc was determined by intensity of signals normalized with b-actin. Data are means ± S.E. of three independent experiments. Statistical analysis was
analyzed by Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.
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apigenin, have PPARc agonist activities [15]. In addition, we previ-
ously reported that PPARc ligands can inhibit IL-4-induced eGT
expression in DND39 cells [16]. We found that pioglitazone, a syn-
thesized PPARc ligand, inhibits IL-4-induced STAT6 phosphoryla-
tion through PPARc, whereas the inhibitory effect of ﬂavones on
STAT6 phosphorylation is independent of PPARc. These results
suggest that PPARc is not a target for the preventive effect of ﬂav-
ones on IgE class switching.
cc is common to the receptor complexes for six different inter-
leukin receptors (IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 receptor) at
present [17]. cc does not bind IL-4 directly but is important for sig-
naling of the type I receptor [4]. In this study, we found that ﬂav-
ones signiﬁcantly reduce the cell surface and protein expression of
cc, suggesting that cc is a target molecule for the inhibitory effect
of ﬂavones on IL-4 signaling. However, the potency of ﬂavones to
inhibit STAT6 and JAK3 phosphorylations is stronger than their po-
tency to reduce cc expression. This discrepancy raised a possibilitythat there is other mode of action for the inhibitory effect of ﬂav-
ones on IL-4 signaling. We examined whether ﬂavones have an
inhibitory effect on heterodimerization of IL-4Ra and cc by the
method of co-immunoprecipitation. We found that ﬂavones had
no inhibitory effect on the association of cc and IL-4Ra (data not
shown). Enzymatic JAK3 inhibition that has been shown by a ﬂavo-
noid kaempferol [18] may be involved in the anti-IL-4 signaling ac-
tion of ﬂavones. It has been reported some natural compounds
such as strictinin, polyphenol in tea, and astragalin, major constit-
uent of ﬂavonoids in persimmon leaf extract, inhibit antigen-spe-
ciﬁc IgE production [12,19]. There are some pharmaceuticals
which target IgE production or JAK3 activity for preventing allergic
diseases [20,21]. To our knowledge, this is a ﬁrst report of chemical
compounds that induce downregulation of cc expression.
In conclusion, we demonstrate here that ﬂavones such as chry-
sin and apigenin can suppress IL-4 signaling by reducing the cell
surface expression of cc. Further studies are needed to elucidate
the mechanisms for negative regulation of cc expression by ﬂav-
S. Yamashita et al. / FEBS Letters 584 (2010) 775–779 779ones. We expect that the results described here may contribute to
the development of means to prevent and cure in type I allergic
diseases.
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